(Q45001921)

8 December 2017

title

High mobility group box chromosomal protein 1 in acute-on-chronic liver failure patients and mice with ConA-induced acute liver injury (English)

1 reference

8 December 2017

1 reference

7

1 reference

8 December 2017

Rong-Rong Zhou

1

1 reference

8 December 2017

Hong-Bo Liu

2

1 reference

8 December 2017

Jian-Ping Peng

3

1 reference

8 December 2017

Yan Huang

4

1 reference

8 December 2017

Ning Li

5

1 reference

8 December 2017

Mei-Fang Xiao

6

1 reference

8 December 2017

Xue-Gong Fan

8

1 reference

8 December 2017

publication date

17 May 2012

1 reference

Experimental and Molecular Pathology

8 December 2017

published in

1 reference

8 December 2017

volume

93

1 reference

8 December 2017

issue

2

1 reference

8 December 2017

page(s)

213-219

1 reference

HMG-1 as a mediator of acute lung inflammation

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

High mobility group box protein-1 (HMGB-1) as a new diagnostic marker in patients with acute appendicitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Telomerase activity of peripheral blood lymphocytes in patients with chronic hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

High-mobility group box 1 protein plasma concentrations during septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Hepatitis C virus infection is blocked by HMGB1 released from virus-infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

HMGB1 contributes to the development of acute lung injury after hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

HMGB1 translocation and expression is caused by warm ischemia reperfusion injury, but not by partial hepatectomy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Alterations in cytokine/chemokine expression during organ-to-organ communication established via acetaminophen-induced toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

The systemic inflammatory response syndrome in acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

HMGB1 develops enhanced proinflammatory activity by binding to cytokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

HMG-1 as a late mediator of endotoxin lethality in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Extracellular role of HMGB1 in inflammation and sepsis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Potential role of high mobility group box 1 in viral infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

HMGB1 cytoplasmic translocation in patients with acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Compartmentalization and its implication for peripheral immunologically-competent cells to the liver in patients with HBV-related acute-on-chronic liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.05.006

10.1016/J.YEXMP.2012.05.006

7 January 2021

Identifiers

DOI

1 reference

8 December 2017

1 reference